new cancer product drive japan sale back half
summari report adjust ep beat
estim consensu compani also
reiter ep guidanc guid
per share essenti bracket consensu think share react
neg weaker-than expect sale growth japan
us
ep guidanc assum averag exchang
rate yen dollar one yen move impact
full-year ep roughli yen
dollar assum averag exchang rate yen
dollar cours use well fargo secur
foreign exchang research forecast increas
ep estim reflect beat
like pre-tax margin japan us
favor versu expect pleas see figur
detail look actual result versu expect japan
us margin driven lower increas futur
polici benefit versu model japan dynam driven
mix shift relat way convers quarterli hedg cost
within aflac japan million lower model
didnt like japan third sector cancer medic
sale yen term versu model
confer call guidanc high singl digit declin
drop function tough comp paus new cancer
sale ahead introduct new cancer product april
launch branch convers continu
expect improv third sector sale back half
continu anticip growth third sector earn
premium sale also weaker expect us
broker-driven sale increasingli shift toward
expect earn premium growth
capit manag bought million share
versu forecast million full-year repurchas
guidanc still billion perhap impli less front-
load repurchas past year
confer call host earn confer call
et april dial number
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
compani prioriti stock list
compani data secur llc estim reuter
million unless otherwis note
compani data secur llc estim
valuat april trade adjust book valu per share less one
standard deviat three year averag price-to-earnings basi afl multipl three-
factset compani data
varianceyoy changecurr unreport qtr data copi past diff pre-tax oper earn total pre-tax oper earn earn per average dilut share outstand amount valu excl oper roe ex fa premium japan premium japan premium total premium sale japan sale japan sale total sale analysisjapan pre-tax pre-tax averag book ex averag ntm earningsaflaflaverag incorpor
compani data secur llc estim
extern websit link includ public maintain control
oper well fargo secur well fargo secur provid product
servic websit view express websit necessarili
repres well fargo secur pleas review applic privaci secur
polici term condit websit visit
million except per share datafisc year end decemb oper earningsaflac total interest pre-tax oper earn earn per share wtd average dilut share outstand share amount per share base per oper roe ex fa valu excl valu incl incl aoci/bv common equiti ex fa incom buyback currenc end com equiti excl fa average com equiti excl fa unreal gains/ loss inv end com equiti insur
price target nc
price target base appli roughli price book multipl forward bvp
estim roughli ex accumul comprehens incom aoci risk target includ
 japanes sale weak higher-than expect loss cost weaker yen asset qualiti
recogn continu work defens play us rate stay low content
sit sidelin current level given headwind neg rate japan potenti
aflac inc base columbu georgia sell supplement health life insur market
administ primarili japanes subsidiari compani profit come
japan compani rank among largest japanes insur product help fill
gap consum primari insur coverag product includ cancer expens insur care plan
supplement gener medic expens plan live benefit plan polici
individu underwritten market worksit independ agent
